120 related articles for article (PubMed ID: 38367938)
1. The individualized delineation of clinical target volume for primary nasopharyngeal carcinoma based on invasion risk of substructures: A prospective, real-world study with a large population.
Wang X; Huang N; Yip PL; Wang J; Huang R; Sun Z; Kang D; He Q; Deng X; Zhao C; Chua MLK; Han F
Radiother Oncol; 2024 May; 194():110154. PubMed ID: 38367938
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of protective effects on salivary and swallowing structures and improvement of late xerostomia and dysphagia by level IIb optimisation in clinical target volume of nasopharyngeal carcinoma.
Zhou J; Wang L; Qiu T; Gao H; Wang L; Huang S; He X; Wu L
BMC Cancer; 2024 May; 24(1):648. PubMed ID: 38802747
[TBL] [Abstract][Full Text] [Related]
3. Selectively sparing of the supraclavicular area during intensity-modulated radiotherapy in nasopharyngeal carcinoma: A double-center observation study.
Guo Q; Lu T; Huang W; Xu H; Zhang Q; Xiao Y; Zhong J; Xie H; Chen J; Zong J; Gong X; Pan J; Li J; Lin S
Radiother Oncol; 2024 Mar; 192():110086. PubMed ID: 38184146
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and toxicity of individualized intensity-modulated radiotherapy based on the tumor extension patterns of nasopharyngeal carcinoma.
Lin L; Yao JJ; Zhou GQ; Guo R; Zhang F; Zhang Y; Xu L; Zhang LL; Lin AH; Ma J; Sun Y
Oncotarget; 2016 Apr; 7(15):20680-90. PubMed ID: 26980744
[TBL] [Abstract][Full Text] [Related]
5. Individualized clinical target volume delineation and efficacy analysis in unilateral nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT): 10-year summary.
Xie DH; Wu Z; Li WZ; Cheng WQ; Tao YL; Wang L; Lv SW; Lin FF; Cui NJ; Zhao C; Ma J; Huang SM; Lu TX; Han YQ; Su Y
J Cancer Res Clin Oncol; 2022 Aug; 148(8):1931-1942. PubMed ID: 35486182
[TBL] [Abstract][Full Text] [Related]
6. Individualization of Clinical Target Volume Delineation Based on Stepwise Spread of Nasopharyngeal Carcinoma: Outcome of More Than a Decade of Clinical Experience.
Sanford NN; Lau J; Lam MB; Juliano AF; Adams JA; Goldberg SI; Lu HM; Lu YC; Liebsch NJ; Curtin HD; Chan AW
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):654-668. PubMed ID: 30712708
[TBL] [Abstract][Full Text] [Related]
7. Unraveling the patterns and pathways of local recurrence of nasopharyngeal carcinoma: evidence for individualized clinical target volume delineation.
Ou X; Yan W; Huang Y; He X; Ying H; Lu X; Zhu H; Wu B; Wang J; Hu C
Radiat Oncol; 2023 Mar; 18(1):55. PubMed ID: 36944958
[TBL] [Abstract][Full Text] [Related]
8. A Prospective 10-Year Observational Study of Reduction of Radiation Therapy Clinical Target Volume and Dose in Early-Stage Nasopharyngeal Carcinoma.
Miao J; Di M; Chen B; Wang L; Cao Y; Xiao W; Wong KH; Huang L; Zhu M; Huang H; Huang S; Han F; Deng X; Xiang Y; Lv X; Xia W; Tan SH; Wee JTS; Guo X; Chua MLK; Zhao C
Int J Radiat Oncol Biol Phys; 2020 Jul; 107(4):672-682. PubMed ID: 32272183
[TBL] [Abstract][Full Text] [Related]
9. Modified reduced-volume intensity-modulated radiation therapy in non-metastatic nasopharyngeal carcinoma: A prospective observation series.
Guo Q; Zheng Y; Lin J; Xu Y; Hu C; Zong J; Lu T; Xu H; Chen B; Liang Q; Xiao Y; Pan J; Lin S
Radiother Oncol; 2021 Mar; 156():251-257. PubMed ID: 33418007
[TBL] [Abstract][Full Text] [Related]
10. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
Han L; Lin SJ; Pan JJ; Chen CB; Zhang Y; Zhang XC; Liao XY; Chen QS
Chin J Cancer; 2010 Feb; 29(2):145-50. PubMed ID: 20109341
[TBL] [Abstract][Full Text] [Related]
12. Locoregional Control and Mild Late Toxicity After Reducing Target Volumes and Radiation Doses in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: 10-Year Results of a Phase 2 Study.
Zhao C; Miao JJ; Hua YJ; Wang L; Han F; Lu LX; Xiao WW; Wu HJ; Zhu MY; Huang SM; Lin CG; Deng XW; Xie CH
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):836-844. PubMed ID: 30954521
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.
Lee N; Xia P; Quivey JM; Sultanem K; Poon I; Akazawa C; Akazawa P; Weinberg V; Fu KK
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):12-22. PubMed ID: 12007936
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy in locally advanced nasopharyngeal carcinoma: Comparative study at SKIMS Tertiary Care Institute.
Fatima K; Andleeb A; Sofi MA; Rasool MT; Fir A; Nasreen S; Dar NA
J Cancer Res Ther; 2022; 18(1):133-139. PubMed ID: 35381774
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Clinical Target Volume Delineation in Local-regional Failure of Nasopharyngeal Carcinoma after Intensity-modulated Radiotherapy.
Yang X; Ren H; Yu W; Zhang X; Sun Y; Shao Y; Zhang L; Li H; Yang X; Fu J
J Cancer; 2020; 11(7):1968-1975. PubMed ID: 32194808
[TBL] [Abstract][Full Text] [Related]
17. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.
Lee N; Xia P; Fischbein NJ; Akazawa P; Akazawa C; Quivey JM
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):49-60. PubMed ID: 12909215
[TBL] [Abstract][Full Text] [Related]
20. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.
Zheng Y; Han F; Xiao W; Xiang Y; Lu L; Deng X; Cui N; Zhao C
Radiat Oncol; 2015 Jan; 10():17. PubMed ID: 25582731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
